Lotus | Operations in Asia | 國產維生素膠囊大剖析

Alvogen is the next generation pharmaceuticals company. Our business model ensures competitive advantage through focused in-house capabilities and a ... Read More

A unique portfolio of high quality and difficult-to-make pharmaceutical products fuels our targeted growth strategy. Alvogen has over 200 strategically selected ... Read More

It became an Alvogen Company in 2014. The primary focus of Lotus is on addressing the fast-growing oncology market. By aligning the company's internal​ ... Read More

Alvogen currently has commercial operations in more than 30 countries, with regional hubs, manufacturing and R&D capabilities in the U.S., South Korea and​ ... Read More

Lotus Pharmaceutical Co., Ltd | 693 位LinkedIn 關注者。The Preferred Global ... It became an Alvogen Company in 2014. The primary focus of Lotus is on ... Read More

2020年4月27日 — It became an Alvogen Company in 2014. The primary focus of Lotus is on addressing the fast-growing oncology market. By aligning the ... Read More

2019年7月25日 — Since Alvogen's acquisition of Lotus in 2014, the company has transformed from a small Taiwanese company to a global pharmaceutical player, ... Read More

2014年1月13日 — Alvogen agreed in December 2013 to become the majority shareholder in Taiwanese Lotus Pharmaceuticals (“Lotus”) through a private ... Read More

沒有這個頁面的資訊。 Read More

Lotus Pharmaceutical is among Taiwan's largest specialty-generic drug ... business, Alvogen Korea's domestic business, Alvogen Pharma India's CRO business ... Read More